Dr. Joshi is a Yale-trained, ABPN board-certified geriatric psychiatrist and recipient of the APA Hartford-Jeste Award. She brings expertise in the full spectrum of late-life psychiatric presentations: Alzheimer's disease and related dementias, neuropsychiatric symptoms of dementia, late-life depression and anxiety, and the complex interplay of psychiatric illness and cognitive decline. She is an active clinical trialist and first-author of multiple peer-reviewed publications on dementia care.

Older adults are frequently prescribed multiple medications by multiple providers, creating a complex and sometimes harmful drug burden. Dr. Joshi specializes in careful, evidence-based deprescribing — reducing or discontinuing medications whose risks outweigh their benefits.

Dr. Joshi combines her board certification in addiction medicine with her geriatric psychiatry subspecialty to offer expert evaluation and management of substance use disorders in older adults — including alcohol use disorder, opioid use disorder, and prescription medication misuse.

ADHD is frequently undiagnosed in older adults, where symptoms may overlap with cognitive decline or polypharmacy. Dr. Joshi offers expert evaluation — carefully distinguishing attentional deficits from dementia-related symptoms — with individualized treatment for the aging brain.

Dr. Joshi provides comprehensive evaluation and medication management for adults across the full range of psychiatric presentations, including depression, anxiety disorders, bipolar disorder, OCD, PTSD, and treatment-resistant conditions. She has particular experience with the complex interplay between psychiatric illness and medical conditions.

Dr. Joshi completed a fellowship in psychoanalysis at the Psychoanalytic Association of New York, with training at NYU Langone. She integrates psychodynamic and psychoanalytic principles into her clinical work, with particular expertise in psychotherapy for older adults — an underserved area where she brings both specialized training and genuine clinical depth.

Hypoactivity in the frontal lobe may lead to deficits in focus, concentration, task salience, and difficulty controlling impulsive or appetitive behaviors. Dr. Rymowicz is an expert in treating ADHD in adults using all available treatment modalities.

Dr. Rymowicz has experience treating withdrawal from the hospital and the home. Outpatient detox treatment, done safely at home, is often possible.

Sedative-hypnotic withdrawal is notoriously difficult. Dr. Rymowicz is an expert in benzodiazepine discontinuation, offering both anticonvulsant-supported rapid tapers and slow, gentle tapers — in accordance with patient preference.

Dr. Rymowicz is an expert in the medication-assisted treatment of substance use disorders, with noted expertise in opioid, stimulant, and alcohol use disorders, offering all available treatments except methadone.

Dr. Rymowicz has extensive experience treating general psychiatric disorders across all treatment settings — from outpatient to acute inpatient to the long-term treatment of the criminally insane. He has experience treating first responders with PTSD.

Dr. Rymowicz is a leading expert in the emerging field of food addiction, having given the first presentations on the topic at the annual meetings of national conferences. As the science progresses and more effective medications become available, we now have highly effective treatments for distressing thoughts about food and for weight loss.